225 related articles for article (PubMed ID: 28753096)
1. Conservative treatment of patients with thromboangiitis obliterans or cannabis-associated arteritis presenting with critical lower limb ischaemia.
Galyfos G; Kerasidis S; Kastrisios G; Giannakakis S; Sachmpazidis I; Anastasiadou C; Geropapas G; Papapetrou A; Papacharalampous G; Maltezos C
Vasa; 2017 Oct; 46(6):471-475. PubMed ID: 28753096
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of intravenous ilomedin infusion and smoking cessation in the treatment of acutely symptomatic Buerger disease.
Spanos K; Georgiou E; Saleptsis V; Athanasoulas A; Sakkas L; Giannoukas AD
Angiology; 2015 Feb; 66(2):114-7. PubMed ID: 24366824
[TBL] [Abstract][Full Text] [Related]
3. Is thromboangiitis obliterans presentation influenced by cannabis addiction?
Martin-Blondel G; Koskas F; Cacoub P; Sène D
Ann Vasc Surg; 2011 May; 25(4):469-73. PubMed ID: 21549914
[TBL] [Abstract][Full Text] [Related]
4. Endovascular Treatment of Thromboangiitis Obliterans (Buerger's Disease).
Modaghegh MS; Hafezi S
Vasc Endovascular Surg; 2018 Feb; 52(2):124-130. PubMed ID: 29237360
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive Transcutaneous Monitoring in Long-Term Follow-Up of Patients With Thromboangiitis Obliterans Treated With Intravenous Iloprost.
Melillo E; Grigoratos C; Sanctis FD; Spontoni P; Nuti M; Dell'Omodarme M; Ferrari M; Balbarini A
Angiology; 2015 Jul; 66(6):531-8. PubMed ID: 25005765
[TBL] [Abstract][Full Text] [Related]
6. Endovascular Treatment of Critical Limb Ischemia in Buerger Disease (Thromboangiitis Obliterans) With Midterm Follow-Up: A Viable Option When Bypass Surgery Is Not Feasible.
Uyanık SA; Öğüşlü U; Aminu IS; Yılmaz B; Çevik H; Atlı E; Gümüş B
AJR Am J Roentgenol; 2021 Feb; 216(2):421-427. PubMed ID: 33325735
[No Abstract] [Full Text] [Related]
7. Lumbar sympathectomy versus prostanoids for critical limb ischaemia due to non-reconstructable peripheral arterial disease.
Sen I; Agarwal S; Tharyan P; Forster R
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD009366. PubMed ID: 29658630
[TBL] [Abstract][Full Text] [Related]
8. A stable prostacyclin analogue (iloprost) in the treatment of Buerger's disease: a prospective analysis of 150 patients.
Bozkurt AK; Cengiz K; Arslan C; Mine DY; Oner S; Deniz DB; Ufuk D
Ann Thorac Cardiovasc Surg; 2013; 19(2):120-5. PubMed ID: 22971807
[TBL] [Abstract][Full Text] [Related]
9. Intravenous iloprost for treatment of critical limb ischemia in patients unsuitable for revascularization.
Çevirme D; Aksoy E; Gül YG; Erdem H; Adademir T; Köksal C; Bozkurt K
Vascular; 2015 Oct; 23(5):483-9. PubMed ID: 25315792
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological treatment for Buerger's disease.
Cacione DG; Macedo CR; do Carmo Novaes F; Baptista-Silva JC
Cochrane Database Syst Rev; 2020 May; 5(5):CD011033. PubMed ID: 32364620
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Anticoagulant Therapy with Low-Molecular-Weight Heparin (LMWH) and Warfarin for Thromboangiitis Obliterans (TAO).
Gao J; Huang L; Wang J
Curr Vasc Pharmacol; 2021; 19(6):655-662. PubMed ID: 33461467
[TBL] [Abstract][Full Text] [Related]
12. Autologous bone marrow-derived mononuclear cell therapy in Chinese patients with critical limb ischemia due to thromboangiitis obliterans: 10-year results.
Guo J; Guo L; Cui S; Tong Z; Dardik A; Gu Y
Stem Cell Res Ther; 2018 Feb; 9(1):43. PubMed ID: 29471870
[TBL] [Abstract][Full Text] [Related]
13. Cannabis-associated arteritis.
Grotenhermen F
Vasa; 2010 Feb; 39(1):43-53. PubMed ID: 20186675
[TBL] [Abstract][Full Text] [Related]
14. Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study.
Fiessinger JN; Schäfer M
Lancet; 1990 Mar; 335(8689):555-7. PubMed ID: 1689791
[TBL] [Abstract][Full Text] [Related]
15. Endovascular treatment of Buerger's disease in patients with critical limb ischaemia.
Serefli D; Saydam O
Cardiovasc J Afr; 2022 Sep-Oct 23; 33(5):254-259. PubMed ID: 35789369
[TBL] [Abstract][Full Text] [Related]
16. [THROMBOANGIITIS OBLITERANS (BUERGER'S DISEASE)].
Fiessinger JN; Frank M
Rev Prat; 2015 Oct; 65(8):1079-83. PubMed ID: 26749712
[TBL] [Abstract][Full Text] [Related]
17. Effects of cilostazol on arterial wound healing: a retrospective analysis.
Resnick KA; Gordon IL
Ann Vasc Surg; 2014 Aug; 28(6):1513-21. PubMed ID: 24561209
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of intravenous iloprost (Ilomedin®) in salvage of the only extremity in a patient with thrombangiitis obliterans].
Gaĭsin IR; Bagautdinova ZR; Trukhina AA; Burlaeva NA; Gibadullina LR; Timonin DV; Smirnov IA; maksimov NI
Angiol Sosud Khir; 2014; 20(2):150-6. PubMed ID: 24961337
[TBL] [Abstract][Full Text] [Related]
19. Cannabis arteritis presenting with Raynaud's and digital ulcerations: a case-based review of a controversial thromboangiitis obliterans-like condition.
Pilitsi E; Kennamer B; Trepanowski N; Gonzalez R; Trojanowski M; Phillips T; Lam CS
Clin Rheumatol; 2023 Jul; 42(7):1981-1985. PubMed ID: 37097526
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors of ulcer healing and amputation-free survival in patients with critical limb ischemia.
Furuyama T; Onohara T; Yamashita S; Yoshiga R; Yoshiya K; Inoue K; Morisaki K; Kyuragi R; Matsumoto T; Maehara Y
Vascular; 2018 Dec; 26(6):626-633. PubMed ID: 30003829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
